Wiktoria E. Krakowiak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wiktoria E. Krakowiak has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Aneta Węgierek-Ciuk
Institute of Biology, Jan Kochanowski University, 25-406 Kielce, Poland
2 shared publications - Halina Lisowska
Institute of Biology, Jan Kochanowski University, Kielce, Poland
2 shared publications Kinga Pasińska
2 shared publications- Magdalena Płódowska
Institute of Biology, Jan Kochanowski University, Kielce, Poland
2 shared publications Andrzej Wojcik
Centre for Radiation Protection Research, MBW Department, Stockholm University, Sweden
1 shared publication- Andrzej Wojcik
Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
1 shared publication
Latest Publications
- 1 January 2026
- Published by Termedia Sp. z.o.o. in Medical Studies
- Vol. 42 (1) , 168-173
Boron neutron capture therapy – a brief review of principles and clinical applications
Boron neutron capture therapy (BNCT) exploits alpha and lithium particles produced in the boron-10 fission reaction (10B(n,α)7Li) with epithermal neutrons to inactivate cancer cells in the tumour volume ranges of produced alpha and lithium particles are limited to individual cells, so the boron-10 atoms should be located only in the target cancer cells. First, there is a need to administer to the patient the boron-10 carrier, which selectively deposits boron-10 atoms in cancer cells. Next, an external beam of epithermal neutrons must be delivered to the treated volume. BNCT is thus a bimodal method, combining epithermal neutron beam teletherapy with systemic therapy. Although BNCT is still under development, recent advances in boron-10 delivery agents and in accelerator-based epithermal neutron beam generation offer a new perspective for BNCT. These advances and some clinical applications of BNCT are briefly reviewed.
- 1 January 2026
- Published by Termedia Sp. z.o.o. in Medical Studies
- Vol. 42 (1) , 168-173
Boron neutron capture therapy – a brief review of principles and clinical applications
Boron neutron capture therapy (BNCT) exploits alpha and lithium particles produced in the boron-10 fission reaction (10B(n,α)7Li) with epithermal neutrons to inactivate cancer cells in the tumour volume ranges of produced alpha and lithium particles are limited to individual cells, so the boron-10 atoms should be located only in the target cancer cells. First, there is a need to administer to the patient the boron-10 carrier, which selectively deposits boron-10 atoms in cancer cells. Next, an external beam of epithermal neutrons must be delivered to the treated volume. BNCT is thus a bimodal method, combining epithermal neutron beam teletherapy with systemic therapy. Although BNCT is still under development, recent advances in boron-10 delivery agents and in accelerator-based epithermal neutron beam generation offer a new perspective for BNCT. These advances and some clinical applications of BNCT are briefly reviewed.
- Open Access
- 23 July 2025
- Published by Elsevier in DNA Repair
- Vol. 152, 103875
DNA damage response of U2OS cells to low doses of gamma radiation delivered at very low dose rate
- 23 July 2025
- Published by Elsevier in DNA Repair
- Vol. 152, 103875
Open AccessDNA damage response of U2OS cells to low doses of gamma radiation delivered at very low dose rate